Connaught Laboratories

Connaught Laboratories (pronunciation: /ˈkɒnɔːt/), also known as Connaught Labs, is a prominent biomedical research institute and vaccine production facility. The name "Connaught" is derived from the title of the Duke of Connaught, the third son of Queen Victoria, who served as the Governor General of Canada from 1911 to 1916.

History

Connaught Laboratories was established in 1914 as part of the University of Toronto's Antitoxin Laboratory. The laboratory was initially focused on the production of diphtheria antitoxin. Over the years, it expanded its research and production to include a wide range of vaccines and other biomedical products.

Research and Production

Connaught Laboratories has been involved in the research and production of numerous vaccines, including those for polio, measles, mumps, and rubella. The laboratory played a significant role in the development of the Salk vaccine, the first effective polio vaccine.

Legacy

Today, Connaught Laboratories is part of Sanofi Pasteur, the vaccines division of the multinational pharmaceutical company Sanofi. The laboratory continues to be a leading center for vaccine research and production.

Related Terms

External links

Medical encyclopedia article on Connaught Laboratories
Wikipedia's article - Connaught Laboratories

This WikiMD dictionary article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Connaught Laboratories